Coronaviruses and Nature’s Pharmacy for the Relief of Coronavirus Disease 2019
Open Access
- 6 October 2020
- journal article
- review article
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 30 (5) , 603-621
Abstract
No abstract availableKeywords
Funding Information
- None (N/A)
This publication has 143 references indexed in Scilit:
- Tea: A native source of antimicrobial agentsFood Research International, 2013
- Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assayAntiviral Research, 2011
- Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusionVirology, 2011
- Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutininAntiviral Research, 2011
- A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple MechanismsJournal of Virology, 2010
- Medicinal herbal extracts of Sophorae radix Acanthopanacis cortex Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitroAntiviral Therapy, 2010
- Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infectionAntiviral Research, 2009
- In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortexJournal of Clinical Virology, 2008
- Complete genomic sequences, a key residue in the spike protein and deletions in nonstructural protein 3b of US strains of the virulent and attenuated coronaviruses, transmissible gastroenteritis virus and porcine respiratory coronavirusVirology, 2007
- Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.Chemical and Pharmaceutical Bulletin, 1986